<DOC>
	<DOCNO>NCT01388296</DOCNO>
	<brief_summary>target study assess minimum alveolar concentration sevoflurane maintain theBispectral Index 50.The minimum alveolar concentration ( MAC ) maintain Bispectral Index 50 ( MACBIS50 ) sevoflurane report previously adult Body Mass Index ( BMI ) &lt; 40 0.97 enfant 2.83 % , However , study assess theBispectral Index 50 ( MACBIS50 ) morbidly obese patient ( BMI &gt; 40 ) . The first aim study ass MACBIS50 sevoflurane morbidly obese patient BMI 40 - 70 use Continuous Reassessment Method ( CRM ) 80 % patient .</brief_summary>
	<brief_title>Minimum Alveolar Concentrations Sevoflurane Maintaining Bispectral Index Below 50 Morbidly Obese Patients</brief_title>
	<detailed_description>After ethical committee approval write informed consent , 30 morbidly obese adult patient , BMI 40- 70Kg/m² , ASA physical status 1 2 , age 18-49 yr , , undergo elective bariatric surgery general anesthesia use sevoflurane , include study . Monitoring consist noninvasive blood pressure , Electrocardiogram ( ECG ) , pulse oximetry , BIS . All subject receive standard dose 2 mcg/kg fentanyl approximately 20 min induction general anesthesia . standard BIS® monitor strip apply fentanyl administration induction general anesthesia . Induction perform patient 2m/kg propofol , 0.2 mg/kg cisatracuruim , follow direct laryngoscopy tracheal intubation . Therefore , BIS reach &gt; 65 , sevoflurane start immediately predetermine dose . The endtidal sevoflurane concentration adjust start dose first cohort patient 1 % maintain 10 min ensure equilibration cerebral anesthetic partial pressure follow 1-min assessment BIS take 10-s interval . Briefly , first dose give first patient next dos give accord follow rule : subject responds positively ( BIS &lt; 50 ) , dose decrease one step next subject , conversely , subject respond ( BIS &gt; 50 ) , dose increase one step . The dose adjustment 0.2 % sevoflurane . The CRM use calculate dose adjustment every cohort number patient every cohort .</detailed_description>
	<mesh_term>Sevoflurane</mesh_term>
	<criteria>morbidly obese patient BMI 4070 age : 2040 year Age &lt; 20 &gt; 40 BMI &lt; 40 &gt; 70 comorbidity</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>